Nicotinamide Supplementation in Glaucoma: A Systematic Review of Human Studies
Human evidence supports the biological plausibility of targeting NAM/NAD metabolism in glaucoma and provides preliminary signals of short-term biological and functional effects, but current evidence remains insufficient to support routine high-dose NAM supplementation in clinical practice.